Regulation of human placental drug transporters in HCV infection and their influence on direct acting antiviral medications
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5R00HD068454-05)
- NIH Clinical and Translational Science Award (UL1 TR000001, UL1RR033179)
This publication has 40 references indexed in Scilit:
- Pathogenesis of Hepatitis C During Pregnancy and ChildhoodViruses, 2012
- Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and MicePLOS ONE, 2012
- OATPs, OATs and OCTs: the organic anion and cation transporters of theSLCOandSLC22Agene superfamiliesBritish Journal of Pharmacology, 2012
- Impact of Polyinosinic/Polycytidylic Acid on Placental and Hepatobiliary Drug Transporters in Pregnant RatsDrug Metabolism and Disposition, 2010
- Characterization of the Transport, Metabolism, and Pharmacokinetics of the Dopamine D3 Receptor-Selective Fluorenyl- and 2-Pyridylphenyl Amides Developed for Treatment of Psychostimulant AbuseThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Drug transporters in the human blood‐placental barrierBritish Journal of Pharmacology, 2009
- Pathogen Recognition and Inflammatory Signaling in Innate Immune DefensesClinical Microbiology Reviews, 2009
- Expression and Activity of Toll-Like Receptors 1–9 in the Human Term Placenta and Changes Associated with Labor at TermBiology of Reproduction, 2009
- High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver diseaseThe Journal of Pathology, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001